David Hallett

Chief Scientific Officer at Recursion Pharmaceuticals · 6 reported transactions in 1 company · latest report Aug 17, 2026

Their trades


Recursion PharmaceuticalsRXRX	Shares withheld for tax $84.2K · 26,657 shares	Aug 17, 2026
Recursion PharmaceuticalsRXRX	Shares withheld for tax $81K · 26,657 shares	May 15, 2026
Recursion PharmaceuticalsRXRX	Shares withheld for tax $41.6K · 11,908 shares	Feb 17, 2026
Recursion PharmaceuticalsRXRX	Shares withheld for tax $45.4K · 11,400 shares	Feb 6, 2026
Recursion PharmaceuticalsRXRX	Share award — · 24,254 shares	Feb 6, 2026
Recursion PharmaceuticalsRXRX	Share award — · 502,064 shares	Feb 6, 2026

Aug 17, 2026 · RXRX

$84.2K

May 15, 2026 · RXRX

$81K

Feb 17, 2026 · RXRX

$41.6K

Feb 6, 2026 · RXRX

$45.4K

Feb 6, 2026 · RXRX

24,254

Feb 6, 2026 · RXRX

502,064

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Scientific Officer at Recursion Pharmaceuticals · 6 reported transactions in 1 company · latest report Aug 17, 2026


Recursion PharmaceuticalsRXRX	Shares withheld for tax $84.2K · 26,657 shares	Aug 17, 2026
Recursion PharmaceuticalsRXRX	Shares withheld for tax $81K · 26,657 shares	May 15, 2026
Recursion PharmaceuticalsRXRX	Shares withheld for tax $41.6K · 11,908 shares	Feb 17, 2026
Recursion PharmaceuticalsRXRX	Shares withheld for tax $45.4K · 11,400 shares	Feb 6, 2026
Recursion PharmaceuticalsRXRX	Share award — · 24,254 shares	Feb 6, 2026
Recursion PharmaceuticalsRXRX	Share award — · 502,064 shares	Feb 6, 2026